Company presentations are an integral programming element at the BIO Investor Forum that allow companies to discuss their pipeline, R&D activities, and future goals to this exclusive audience. The conference features 13-minute presentations by over 150 biotech companies poised to join the growth “watch list”, as well as a number of nonprofit and venture philanthropy organizations. The typical audience for all presentations features public and private equity investors, research analysts, investment bankers and industry executives.
Presenters benefit from a critical mass of decision-makers that you want to meet under one roof for two focused days, to tell your company’s story and attract the partners you need to succeed in developing innovations to help patients. Company presenters tend to receive double the number of BIO One-on-One Partnering™ requests than non-presenters, and schedule twice as many meetings than non-presenting companies. Presenting companies are also spotlighted in BIO’s marketing materials leading up to the event, as well as onsite.
Our Sales & Sponsorship team is always ready to support your event engagement. Please feel free to reach out to the team at +1.202.312.9264 or sponsor@bio.org to receive more information.
Are you interested in learning about sponsorship opportunities at the BIO Investor Forum? Fill out the request form below to receive the 2019 sponsorship prospectus.
Our Sales & Sponsorship team is always ready to support your event engagement. Please feel free to reach out to the team at +1.202.312.9264 or sponsor@bio.org to receive more information.
The BIO Investor Forum provides many opportunities for news stories. Complimentary registration is available to applicants with valid press credentials and media is invited to attend all programs. BIO will review submissions in the order they are received and send notification within 48 hours. Instructions for receiving a complimentary media badge will be sent to all approved media.
Affiliated/Credentialed Media (Broadcast, Online, Newspapers, Magazines, Newsletters, etc)
Please be advised you may be asked to provide valid press credentials which include:
• A by-lined article published by their employing news agency within the past six months
• A copy of publication masthead listing the individual’s primary position as an editor or reporter
• Official photo identification issued by employing news agency or government
Freelance Journalists
Freelance writers may apply for complimentary media registration and must present the following:
• A signed letter on company letterhead from your assignment editor confirming your assignment to cover the event
• A by-lined story appearing in a verifiable print or electronic publication dated within the last six months
Bloggers
Bloggers will be considered for media registration on a case-by-case basis, and must provide three of their most recent blog posts on a biotechnology related subject for consideration.
Important Information
Marketing executives, sales representatives, public relations executives, analysts, consultants, authors and researchers may not register as media.
Advanced media registration is encouraged for all types of media including web-based, college and freelance reporters.
Videotaping of sessions is prohibited without signed waivers from all session speakers. Please contact BIO Communications for more information.
BIO Communications is available to assist you with contacting companies and speakers, and setting up interviews. Please contact Theresa Brady if you need assistance.
BIO will provide a fully functioning press work room with computers, internet access and printers.
BIO events attract the most sophisticated investors in the life science community and provide a robust forum for this community to engage in the advancement of promising technologies that improve and save lives. BIO is pleased to provide complimentary registration to qualified investors under BIO’s revised investor policy.
Qualified investors are defined as institutional, private equity, angel and venture investors with funds on-hand, whose primary activity is direct investment in research and development companies (e.g., hedge fund, mutual fund, or venture fund). Equity research analysts from investment banking institutions and buy-side analysts also qualify as investors.
The fund name, portfolio type, and other helpful information is needed for BIO to process your registration appropriately. Receipt of complimentary registration for a prior year's event does not automatically qualify a registrant for complimentary registration in 2019. In cases where no information is attainable via investor relations databases and/or internet searches may be required to provide additional information.
Organizations who apply for investor registration, that have a service providing component to their business model, such as investor relations, contract services, organizations or who host competitive events will be ineligible for complimentary investor registration. Should BIO discover undisclosed information about an organization's business model AFTER an application has been approved, it may be rescinded at BIO’s discretion.
This landmark hotel is in the heart of Union Square. Timeless yet modern, The Westin St Francis Union Square has a vibrant, iconic destination in San Francisco. As the only hotel located directly on Union Square, guest have the benefit of the best shopping, theater and dining options, as well as China Town and the Financial District just minutes away.
Reservations
At this time, regretfully the BIO contracted rooming block at the Westin is full. While there are still rooms available at the Westin St. Francis, they are no longer available at the group rate of $359 which was available through September 23, 2019.
Reservations may still be made online directly with the hotel (https://www.westinstfrancis.com), or by calling 800.WESTIN.1 (800.937.8461). Alternatively, there are other hotel choices close to Union Square.
